| Literature DB >> 24686741 |
Chunkai Wang1, Qingjie Zhao1, Jaeki Min1, Sakthivel Muniyan1, Mireille Vargas1, Xiaofang Wang1, Yuxiang Dong1, R Kiplin Guy1, Ming-Fong Lin1, Jennifer Keiser1, Jonathan L Vennerstrom2.
Abstract
In the early 1980s, the antischistosomal aryl hydantoin Ro 13-3978 (AH01), a close structural analogue of the androgen receptor antagonist nilutamide, was discovered. Administration of 100 mg/kg oral doses of AH01 to mice infected with adult and juvenile Schistosoma mansoni produced 95% and 64% total worm burden reductions, confirming its high activity against adult worms, and showing that AH01 is also effective against juvenile infections. AH01 had no measureable interaction with the androgen receptor in a ligand competition assay, but it did block dihydrotestosterone-induced cell proliferation in an androgen-dependent human prostate cancer cell line. For AH01, nilutamide, and three closely related aryl hydantoin derivatives, there was no correlation between antischistosomal activity and androgen receptor interaction. © The American Society of Tropical Medicine and Hygiene.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24686741 PMCID: PMC4047746 DOI: 10.4269/ajtmh.14-0029
Source DB: PubMed Journal: Am J Trop Med Hyg ISSN: 0002-9637 Impact factor: 2.345